Research from The University of Osaka highlights a new model of a gyroscopic wave energy converter. The device was shown to be capable of absorbing up to half of incoming wave energy across a wide ...
Novartis has confirmed it will discontinue development of a gene therapy for sight-robbing disease geographic atrophy (GA) two years after acquiring its UK-based developer. The GT005 (PPY988) gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results